Company: CRNX
Filing Date: 2025-04-23
Form Type: DEF 14A
Source: 0000950170-25-057452
Chunk: 60

Company: Crinetics Pharmaceuticals, Inc.
Filing Date: 2025-04-23
Form: DEF 14A
Chunk 60
---
 based on the aggregate grant date fair value of the stock and option awards in accordance with Financial Accounting Standards Board Accounting Standards Codification Topic 718. See Note 11 to our consolidated financial statements in our Annual Report on Form 10‑K for the year ended December 31, 2024 filed with the SEC on February 27, 2025, for a discussion of the relevant assumptions used in determining the grant date fair value pursuant to ASC 718. These amounts do not reflect whether the recipient has actually realized or will realize a financial benefit from the awards (such as by exercising stock options). Whether, and to what extent, a named executive officer realizes a financial benefit from the awards will depend on our actual operating performance, stock price fluctuations and the named executive officer's continued employment or service. (2) These amounts represent performance bonuses earned under our executive bonus program, which is described above under “Compensation Discussion and Analysis — Executive Compensation Components — Annual Incentive Awards.” (3) The amounts represent 401(k) plan matching contributions in the amount of $3,000 paid by us and generally available to all full-time U.S. employees. For Dr. Pizzuti, the amount for 2022 also includes $52,340 for reimbursement of relocation expense and a $25,239 tax gross up. (4) Represents a $95,000 signing bonus paid to Dr. Pizzuti in connection with her commencement of employment. 2024 Grants of Plan Based Awards The following table sets forth summary information regarding grants of plan-based awards made to our named executive officers during the year ended December 31, 2024.

<div align='center'>45</div>

|                           |     |          |     |           |     | Estimated Future Payouts Under Non-Equity Incentive 
 Plan Awards(1)                                      |     |            |     |             |     |                     |     |                      |     |          |     |               |
| Name                      |     | Grant    
 Date     |     | Date of   
 Approval  
 of Equity 
 Awards    |     | Threshold ($)                                       |     | Target ($) |     | Maximum ($) |     |           All Other 
               Stock 
              Awards 
 Number of Shares of 
            Stock or 
               Units 
              (#)(2) |     |            All Other 
               Option 
               Awards 
 Number of Securities 
           Underlying 
              Options 
               (#)(3) |     | Exercise 
  or Base 
 Price of 
   Option